2019-nCoV COVID-19 IgM/IgG Rapid test kit
OVID-19 IgG/IgM Rapid comboTest
COVID-19 IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma) is a solid phase immunochromatographic
assay for the rapid, qualitative and differential detection of IgG and IgM antibodies to 2019 Novel Coronavirus in human whole
blood, serum or plasma.
Features & Benefits
• Fast results as soon as 2–10 minutes • Facilitates patient treatment decisions quickly • Simple, time-saving procedure • Little specimens, only 5 μL of serum/plasma or 10 μL of whole blood specimens • All necessary reagents provided & no equipment needed • High sensitivity and specificity
For confirmed coronavirus disease 2019 (COVID-19) cases, reported illnesses have ranged from mild symptoms to severe illness and death. Symptoms can include:
Fever • Cough • Shortness of breath
The virus is thought to spread mainly from person-to-person.
Between people who are in close contact with one another (within about 6 feet). • Via respiratory droplets produced when an infected person coughs or sneezes. • These droplets can land in the mouths or noses of people who are nearby or possibly be inhaled into the lungs.
TAJ PHARMA started working on mRNA vaccine against coronavirus
Taj Pharmaceuticals Biotechnological Division has announced the research in order to create an mRNA vaccine against SARS-COV-2 (coronavirus). Development will be based on previous pipelines for mRNA-oncovaccines creation: an area where the company has a great expertise. The first animal studies are scheduled for the end of April.
According to Abhishek Kumar Singh, TAJ PHARMA CEO, today the whole world is working on the search for coronavirus treatment: “By now, 66 companies around the world have announced the development of drugs against SARS-COV-19, 51 of them are working on vaccines, 15 — on DNA, RNA or small molecules based drugs. In my opinion, the more intellectual forces are involved in solving the problem, the sooner the world can get over this challenge”.
Three vaccine options are planned to be developed; and animal testing is scheduled for late April. The short development period is granted by its mRNA basis. In contrast to the traditional vaccines based on reorganized proteins, manufacturing of small molecules drugs takes less than five to six months.
Since the end of January, researchers from the Dongfang Hospital at Shanghai Tongji University and the Chinese biotechnology company Stemirna have been working on the vaccine. They synthesized matrix ribonucleic acid (mRNA) with several sequences of different antigens. Recently, researchers from the University of Utrecht (Netherlands), in collaboration with the Erasmus University Medical Center and Harbor Biomed, reported the discovery of the first human monoclonal antibody that can block the attachment of the SARS-CoV-2 coronavirus that causes Covid-19.
About the company
Taj Pharmaceuticals is the global leader in generics and one of the India’s top ten pharmaceutical companies. Taj Pharma India play a leading role in therapeutic areas such as cancer, virology and transplantation. The combined strengths of Taj Pharma generics and pharmaceuticals businesses, coupled with expertise in the emerging genetic sciences, equip us to develop integrated healthcare solutions and therapeutic approaches tailored to individual patients’ needs. Taj Pharmaceutical’s products and services address the entire healthcare spectrum, from screening for genetic risk factors, to preventing, diagnosing and treating disease, and monitoring the treatment response.
Taj Pharma India delivers a unique contribution to better healthcare. Taj Pharma India aim to reduce suffering and improve health and quality of life of people all around the world. At Taj Pharmaceuticals, Taj Pharma India have pursued this mission with patience, dedication, imagination and skill, for over a century. Taj Pharma vision is to develop targeted medicines and diagnostic tools that combine to offer patients, physicians and payers better, safer, more cost-effective healthcare.
Once again, welcome to Taj Pharmaceuticals, a great company that is translating a great vision into reality — We Innovate Healthcare.
Taj Pharmaceuticals Limited is committed to earning the trust of doctors, patients and customers every day. Taj Pharma colleagues worldwide believe that trust is not easily granted, and that is the reason Taj Pharma India focus each day on becoming a champion for Taj Pharma stakeholders.
During the past ten years, Taj Pharmaceuticals Group has been building a new kind of health care company. Throughout Taj Pharma Group (India), there’s a desire to build long-term relationships with Taj Pharma stakeholders based on mutual confidence. This is evident in many ways. Taj Pharma scientists are earning trust through the discovery and development of innovative, science-based medicines and services that improve the health and overall well-being of people around the world. Taj Pharma sales professionals, marketing teams, colleagues working at Taj Pharma plants and others throughout the organization at all levels of responsibility take each day as a fresh opportunity to earn trust.
All of this takes hard work, sharp execution, integrity and transparency on the part of Taj Pharmaceuticals Group colleagues. Taj Pharma global team is working to sustain and expand innovative new treatments. Taj Pharma India’re determined to do Taj Pharma part to increase access to better health care for all people. And, Taj Pharma India is focused on becoming the best in three key strategic areas: people, products and processes.
Taj Pharma India’re beginning to see the results of Taj Pharma efforts, but believe the best is yet to come. The test of being a true champion is to never give up and to passionately strive for even better outcomes. From Taj Pharma perspective as a health care company, that means helping people around the world live better and live longer.